Viracta Therapeutics Inc (NASDAQ:VIRX)
| 0.485 BATS BZX Real-Time Price As of 12:45pm ET |  -0.0189 / -3.75%Today’s Change | 0.44 Today|||52-Week Range 2.47 | -66.78% Year-to-Date |
Latest VIRX News | Press Releases
No recent news for Viracta Therapeutics Inc.
Today’s Trading
| Previous close | 0.50 |
| Today’s open | 0.49 |
| Day’s range | 0.48 - 0.49 |
| Volume | 1,978 |
| Average volume (3 months) | 108,943 |
| Market cap | $18.3M |
Data as of 12:45pm ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | +63.85% |
| Earnings growth (this year) | +8.85% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.34 |
Competitors
| ---- | ||
| ONCTOncternal Therapeuti... | +0.04 | +12.81% |
| DRRXDURECT Corp | +0.03 | +4.43% |
| NRBONeurobo Pharmaceutic... | +0.01 | +1.20% |
Data as of 12:41pm ET, 12/06/2023
Financials
| Next reporting date | March 12, 2024 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$49.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cardiff, California |
Forecasts
